BCL2 and ovarian cancer: As shown in Fig. 2e, f, the overexpression of miR-17-5p inhibited the ability of chemotherapy to increase BAX expression, while the Bcl-2 expression was increased in miR-17-5p overexpressed ovarian cancer cells.